LOGO
LOGO

Drug Development

US Announces Agreement With UK On Pharmaceutical Pricing

By Joji Xavier   ✉   | Published:   | Follow Us On Google News
usukmedicines 03122025 lt

The Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services have announced that the U.S. Government has reached an agreement in principle on pharmaceutical pricing with the United Kingdom.

In the U.S.-U.K. Economic Prosperity Deal, President Donald Trump and Prime Minister Keir Starmer agreed to address long-standing imbalances in bilateral pharmaceutical trade by improving the overall environment for pharmaceutical companies operating in the United Kingdom.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Health News

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19